Pathogenic and Therapeutic Role of Vitamin D in Antiphospholipid Syndrome Patients

A Critical Evaluation of Vitamin D - Clinical Overview ◽

10.5772/65071 ◽

2017 ◽

Cited By ~ 1

Author(s):

Svetlana Jelic ◽

Dejan Nikolic ◽

Dragomir Marisavljević ◽

Ljudmila Stojanovich

Keyword(s):

Vitamin D ◽

Antiphospholipid Syndrome ◽

Therapeutic Role

Download Full-text

Therapeutic Role of Vitamin D in Cardiovascular Disease: Emerging Evidence

Cardiovascular Pharmacology Open Access ◽

10.4172/2329-6607.1000237 ◽

2018 ◽

Vol 07 (02) ◽

Author(s):

Moretti HD ◽

Grant WB ◽

Berry BD ◽

Colucci VJ

Keyword(s):

Cardiovascular Disease ◽

Vitamin D ◽

Therapeutic Role

Download Full-text

The role of vitamin D in metabolic and reproductive disturbances of polycystic ovary syndrome: A narrative mini-review

International Journal for Vitamin and Nutrition Research ◽

10.1024/0300-9831/a000691 ◽

2020 ◽

pp. 1-8

Author(s):

Daniela Menichini ◽

Gianpiero Forte ◽

Beatrice Orrù ◽

Giuseppe Gullo ◽

Vittorio Unfer ◽

...

Keyword(s):

Vitamin D ◽

Polycystic Ovary Syndrome ◽

Embryo Quality ◽

Polycystic Ovary ◽

Vitamin D Supplementation ◽

Endometrial Receptivity ◽

Metabolic Disturbances ◽

Ovary Syndrome ◽

Beneficial Role

Abstract. Vitamin D is a secosteroid hormone that plays a pivotal role in several metabolic and reproductive pathways in humans. Increasing evidence supports the role of vitamin D deficiency in metabolic disturbances and infertility in women with polycystic ovary syndrome (PCOS). Indeed, supplementation with vitamin D seems to have a beneficial role on insulin resistance and endometrial receptivity. On the other hand, exceedingly high levels of vitamin D appear to play a detrimental role on oocytes development and embryo quality. In the current review, we summarize the available evidence about the topic, aiming to suggest the best supplementation strategy in women with PCOS or, more generally, in those with metabolic disturbances and infertility. Based on the retrieved data, vitamin D seems to have a beneficial role on IR, insulin sensitivity and endometrial receptivity, but high levels and incorrect timing of administration seem to have a detrimental role on oocytes development and embryo quality. Therefore, we encourage a low dose supplementation (400–800 IU/day) particularly in vitamin D deficient women that present metabolic disturbances like PCOS. As far as the reproductive health, we advise vitamin D supplementation in selected populations, only during specific moments of the ovarian cycle, to support the luteal phase. However, ambiguities about dosage and timing of the supplementation still emerge from the clinical studies published to date and further studies are required.

Download Full-text